rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-12-4
|
pubmed:databankReference |
|
pubmed:abstractText |
In people with screen-detected type 2 diabetes in primary care, (1) to assess adherence to guidelines, recommending consultation with the GP every three months and treatment initiation with an ACE inhibitor or an angiotensin-II receptor antagonist when systolic BP was > 120 mmHg and/or diastolic BP was > 80 mmHg, and (2) to identify predictors for adherence.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1502-7724
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
223-31
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19929182-Adult,
pubmed-meshheading:19929182-Aged,
pubmed-meshheading:19929182-Angiotensin II Type 2 Receptor Blockers,
pubmed-meshheading:19929182-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19929182-Blood Pressure Determination,
pubmed-meshheading:19929182-Denmark,
pubmed-meshheading:19929182-Diabetes Mellitus, Type 2,
pubmed-meshheading:19929182-Family Practice,
pubmed-meshheading:19929182-Female,
pubmed-meshheading:19929182-Follow-Up Studies,
pubmed-meshheading:19929182-Guideline Adherence,
pubmed-meshheading:19929182-Humans,
pubmed-meshheading:19929182-Male,
pubmed-meshheading:19929182-Middle Aged,
pubmed-meshheading:19929182-Patient Compliance,
pubmed-meshheading:19929182-Prospective Studies,
pubmed-meshheading:19929182-Receptor, Angiotensin, Type 2
|
pubmed:year |
2009
|
pubmed:articleTitle |
Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark.
|
pubmed:affiliation |
Department of General Practice, School of Public Health, Aarhus University, Gentofte, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|